Clinical Trial Update: A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating weekly docetaxel (Taxotere) plus capecitabine (Xeloda) for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Cancer Research Network | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED